Our results showed that vitamin D supplementation was associated with an increased GPx activity in both regimens, significantly reduced IL-6 levels in the bolus group, and improvements in anxiety and depression scores, particularly among patients receiving daily supplementation. This evidence concerns the gene IL6 and Anxiety.